Altria Group (MO) vs Orchestra BioMed (OBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Orchestra BioMed (OBIO) has outperformed Altria Group (MO) over the past year, gaining 45.3% versus a gain of 28.7%. Over five years, MO leads with a +71.2% price change compared with -33.3% for OBIO. Altria Group is the larger company by market cap ($124.54 billion vs $517.9 million), about 240.5 times the size, while Orchestra BioMed is growing revenue faster (+1169.2% vs -3.1%).
Altria Group pays a dividend yielding 5.73%, while Orchestra BioMed does not currently pay one. Altria Group converts more of its revenue into profit, with a net margin of 29.8% versus -157.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MO | OBIO |
|---|---|---|
| Share price | $74.87 | $6.58 |
| Market cap | $124.54B | $517.88M |
| 1-day change | +0.25% | -6.00% |
| YTD return | +29.85% | +58.55% |
| 1-year return | +28.66% | +45.25% |
| 5-year return | +71.17% | -33.27% |
| P/E ratio (TTM) | 15.44 | — |
| Forward P/E | 12.64 | — |
| EPS (TTM) | $4.85 | $-0.75 |
| Dividend yield | 5.73% | 0.00% |
| Annual dividend | $4.29 | $0.00 |
| Revenue (latest FY) | $23.28B | $33.48M |
| Revenue growth (YoY) | -3.08% | +1169.22% |
| Net income (latest FY) | $6.95B | $-52.70M |
| Gross margin | 62.47% | 99.43% |
| Operating margin | 42.52% | -154.73% |
| Net margin | 29.84% | -157.40% |
| 52-week high | $79.97 | $7.83 |
| 52-week low | $54.70 | $3.46 |
| Distance from 52-week high | -6.38% | -15.91% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | -1.90% | +101.98% |
| Average volume | 8.05M | 420.19K |
| Shares outstanding | 1.66B | 78.70M |
| Employees | 5,900 | 86 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Altria Group is about 240.5 times larger than Orchestra BioMed by market value ($124.54B vs $517.88M).
- OBIO has outperformed MO by 16.6 percentage points over the past year.
- Altria Group offers a meaningfully higher dividend yield (5.73% vs 0.00%).
- Altria Group is more profitable, keeping 29.8 cents of every revenue dollar as net income versus -157.4 cents for Orchestra BioMed.
- Orchestra BioMed grew revenue faster in its latest fiscal year (+1169.22% vs -3.08%).
About Altria Group
MO stock →Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Health Care · Medicinal Chemicals and Botanical Products · 5,900 employees
About Orchestra BioMed
OBIO stock →Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Health Care · Medicinal Chemicals and Botanical Products · 86 employees
MO vs OBIO FAQ
Which is bigger, Altria Group or Orchestra BioMed?
Altria Group (MO) is larger, with a market capitalization of $124.54B compared with $517.88M for Orchestra BioMed (OBIO).
Which stock has performed better over the past year, MO or OBIO?
OBIO returned +45.25% over the past 12 months, compared with +28.66% for MO (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Altria Group or Orchestra BioMed?
Altria Group pays a dividend yielding 5.73%, while Orchestra BioMed does not currently pay a regular dividend.
Are Altria Group and Orchestra BioMed in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.